2017 Publications

Tong A, Manns B, Hemmelgarn B, Wheeler DC, Evangelidis N, Tugwell P, Crowe S, Van Biesen W, Winkelmayer WC, O’Donoghue D, Tam-Tham H, Shen J, Pinter J, Larkins N, Youssouf S, Mandayam S, Ju A, Craig JC, on behalf of the SONG-HD Investigators. Establishing core outcome domains in hemodialysis: report of the Standardised Outcomes in Nephrology – Hemodialysis (SONG-HD) consensus workshops. American Journal of Kidney Disease 69(1): 97-107, 2016.

Small D, Weston K, Howden E, Briskey D, Johnson DW, Isbel NM, Gobe GC, Coombes J. Effects of exercise and lifestyle intervention on oxidative stress in chronic kidney disease. Redox Report 2017 Jan 11:1-10. doi: 10.1080/13510002.2016.1276314. [Epub ahead of print].

Chan S, Burke MT, Johnson DW, Francis RS, Mudge DW. Tacrolimus toxicity due to biliary obstruction in a combined liver and kidney transplant recipient. Case Reports in Transplantation 2017 doi:10.1155/2017/9096435.

Boudville N, Cho Y, Equinox KL, Figueiredo AE, Hawley CM, Johnson DW, Jose M, Lee A, Maley MAL, Moodie J, Pascoe EM, Steiner GZ, Tomlins M, Voss D, Chow J. Teaching peritoneal dialysis in Australia: an opportunity for improvement. Nephrology (In press; Acceptance date 28 December 2016).

Mahmood U, Johnson DW, Fahim MA. Cardiac biomarkers in dialysis. AIMS Genetics 4(1): 1-20, 2016.

Shen K, Cho Y, Pascoe EM, Hawley CM, Oliver V, Hughes KM, Baer R, Frazier J, Jarvis E, Tan KS, Liu X, Gobe GC, Johnson DW. The SIESTA trial – a randomized Study Investigating the Efficacy, Safety and Tolerability of Acupressure versus sham therapy for improving sleep quality in patients with end-stage kidney disease on hemodialysis. Evidence-Based Complementary and Alternative Medicine (In press; Acceptance date 26 January 2017).

Nataatmadja M, Cho Y, Pascoe EM, Darssan D, Hawley CM, Johnson DW. Association between peritoneal glucose exposure and peritonitis in peritoneal dialysis patients: the balANZ trial. Peritoneal Dialysis International (In press; Acceptance date 6 February 2017).

Saglimbene V, Palmer SC, Craig JC, Nicolucci A, Perkovic V, Tonelli M, Johnson DW, Lucisano G, Williams G, Valentini M, D’Alonzo D, Pellegrini F, Santoro A, Strippoli P, Triolo G, Salomone M, Maffei S, Ruospo M, Hegbrant J, Tognoni G, Strippoli GFM, for the CE-DOSE Study Investigators. High versus low dose erythropoiesis-stimulating agents in people with end-stage kidney disease treated with haemodialysis (C.E. DOSE): a pragmatic, multicentre, randomised controlled trial. PLOS One (In press; Acceptance date 10 February 2017).

Kelly JT, Rossi M, Johnson DW, Campbell KL. Beyond Sodium, Phosphate and Potassium: Potential Dietary Interventions in Kidney Disease. Seminars in Dialysis 2017 [ePub ahead of print]. doi:10.1111/sdi.12580

Szeto CC, Li PKT, Johnson DW, Bernardini J, Dong J, Figueiredo AE, Ito Y, Kazancioglu R, Moraes T, Van Esch S, Brown EA. ISPD Catheter-Related Infection Recommendations: 2017 Update. Peritoneal Dialysis International (In press; Acceptance date 1 March 2017).

Francis A, Johnson DW, Craig JC, Wong G. Incidence and predictors of cancer following kidney transplantation in childhood. American Journal of Transplantation (In press; Acceptance date 2 March 2017).

Bello AK, Levin A, Tonelli M, Okpechi IG, Feehally J, Harris D, Jindal K, Salako B, Rateb A, Osman MA, Qarn B, Saad S, Lunney M, Wiebe N, Ye F, Johnson DW (2017). Global Kidney Health Atlas: A report by the International Society of Nephrology on the current state of organization and structures for kidney care across the globe. International Society of Nephrology, Brussels, Belgium.

Cho Y, Htay H, Johnson DW. Centre effects and peritoneal dialysis-related peritonitis. Nephrology Dialysis Transplantation (In press; Acceptance date 7 March 2017).

Chan S, Au K, Francis R, Mudge DW, Johnson DW, Rahman T. An Update on Hepatorenal Syndrome. Journal of Renal and Hepatic Disorders 1(1):1–8, 2017.

Small D, Weston K, Howden E, Briskey D, Johnson DW, Isbel NM, Gobe GC, Coombes J. Effects of exercise and lifestyle intervention on oxidative stress in chronic kidney disease. Redox Report 22:127-36, 2017.

Luyckx VA, Tuttle KR, Garcia GG, Gharbi MB, Heerspink HJL, Johnson DW, Liu ZH, Massy ZA, Moe O, Nelson RG, Sola L, Wheeler DC, White SL. Reducing major risk actors for chronic kidney disease. Kidney International (In press; Acceptance date 1 April 2017).

Pollock C, Zuk A, Anders HJ, Ganji MR, Johnson DW, Kasiske B, Langham R, Pecoits-Filho R, Remuzzi G, Rossert J, Suzuki Y, Tanaka T, Walker R, Yang CW, Bonventre JV. The establishment and validation of novel therapeutic targets to retard progression of chronic kidney disease. Kidney International (In press; Acceptance date 1 April 2017).

Levin A, Tonelli M, Eckardt KU, Bonventre J, Coresh J, Donner JA, Fox C, Jardine M, Kasiske B, Köttgen A, Kretzler M, Lambers Heerspink H, Levey A, Luyckx V, Mehta R, Moe O, Obrador G, Pannu N, Parikh C, Perkovic V, Pollock C, Stenvinkel P, Tuttle K, Wheeler D, Adu D, Agarwal SK, Alrukhaimi M, Anders HJ, Ashuntantang G, Basnet S, Bello A, Gharbi MB, Chailimpamontree W, Correa-Rotter R, Craig JC, Douthat WG, Feehally J, Feldman HI, Fogo A, Ganji M, Garcia-Garcia G, Harris D, Hemmelgarn B, Jha V, Johnson DW, Kazancioglu R, Langham R, Liu Z, Massy ZA, Nangaku M, Nelson R, O’Donoghue D, Okpechi I, Pecoits-Filho R, Powe NR, Remuzzi G, Rossert J, Sola L, Stengel B, Sumaili E, Tanaka T, Tatiyanupanwong S, Thomas B, Uhlig K, Walker R, White S, Wiecek A, Yang CW. Global Kidney Health 2017 and beyond: A roadmap for closing gaps in care, research, and policy. Lancet (In press; Acceptance date 1 April 2017).

Bello AK, A, Tonelli M, Okpechi IG, Feehally J, Harris DC, Jindal K, B, Rateb A, Osman MA, Qarn B, Saad S, Lunney M, Wiebe1 N, Ye F, Johnson DW. Assessment of global kidney health care status. JAMA (In press; Acceptance date 5 April 2017).

Htay H, Cho Y, Pascoe EM, Darssan D, Nadeau-Fredette AC, Hawley CM, Clayton PA, Borlace M, Badve SV, Sud K, Boudville N, McDonald SP, Johnson DW. Multi-center registry analysis of center characteristics associated with technique failure in incident peritoneal dialysis patients. Clinical Journal of the American Society of Nephrology (In press; Acceptance date 5 April 2017).

Campbell D, Mudge DW, Craig JC, Johnson DW, Tong A, Strippoli GFM. Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients. Cochrane Database of Systematic Reviews 2017, Issue 4. Art. No.: CD004679. DOI: 10.1002/14651858.CD004679.pub3.

Brown EA, Bargman J, van Biesen W, Chang MY, Finkelstein FO, Hurst H, Johnson DW, Kawanishi H, Lambie M, de Moraes TP, Morelle J, Woodrow G. Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis: Position paper for ISPD – update 2017. Peritoneal Dialysis International (In press; Acceptance date 4 April 2017).

Kelly JT, Rossi M, Johnson DW, Campbell KL. Beyond Sodium, Phosphate and Potassium: Potential Dietary Interventions in Kidney Disease. Seminars in Dialysis 30(3):197-202, 2017

Palmer SC, Maggo JK, Campbell KL, Craig JC, Johnson DW, Sutanto B, Ruospo M, Tong A, Strippoli GFM. Dietary interventions for adults with chronic kidney disease. Cochrane Database of Systematic Reviews 2017, Issue 4. Art. No.: CD011998. DOI: 10.1002/14651858.CD011998.pub2.

Htay H, Cho Y, Pascoe EM, Darssan D, Hawley CM, Clayton PA, Borlace M, Badve SV, Sud K, Boudville, McDonald SP, Johnson DW. Outcomes of Corynebacterium peritonitis: a multi-centre registry analysis. Peritoneal Dialysis International (In press; Acceptance date 20 April 2017).

Canadian Society of Nephrology Dr Dimitrios Oreopoulos Memorial Award, Awarded at the Canadian Society of Nephrology Annual General Meeting, Montreal, May 2017

Htay H, Cho Y, Pascoe EM, Darssan D, Hawley CM, Clayton PA, Borlace M, Badve SV, Kamal Sud, Boudville N, McDonald SP, Johnson DW. Outcomes of Corynebacterium peritonitis: a multi-centre registry analysis. Peritonea Dialysis Internatonal (In press; Acceptance date 2 May 2017).

Manera KE, Tong A, Craig JC, Brown EA, Brunier G, Dong J, Dunning T, Mehrotra R, Naicker S, Pecoits-Filho R, Perl J, Wang AY, Wilkie M, Howell M, Sautenet B, Evangelidis N, Shen JI, Johnson DW. Standardised Outcomes in Nephrology – Peritoneal Dialysis (SONG-PD): study protocol for establishing a core outcome set in peritoneal dialysis. Peritoneal Dialysis International (In press; Acceptance date 2 May 2017).

Johnson DW, Cleland B, Eris J, Rafferty T, Sud K, Chow J. Administration of erythropoiesis-stimulating agents in haemodialysis patients: a time and motion study. Journal of Renal Care (in press; Acceptance date 10 May 2017).

Neuen BL, Chadban SJ, Demaio AR, Johnson DW, Perkovic V. Chronic kidney disease and the global NCDs agenda in 2017. BMJ Global Health (In press; Acceptance date 19 May 2017).

Li P, Chow KM, Johnson DW, Lameire N, Mehrotra R, Naicker S, Pecoits-Filho R, Yu X, van de Luijtgaarden M, Jager K. Changes in the worldwide epidemiology of peritoneal dialysis. Nature Reviews Nephrology 13(2):90-103, 2017

Briskey D, Tucker P, Johnson DW, Coombes JS. The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development. Clinical and Experimental Nephrology 21(1):7-15, 2017.

Badve SV, Pascoe EM, Burke M, Clayton PA, Campbell SB, Lim WH, McDonald SP, Wong G, Johnson DW. Mammalian target of rapamycin inhibitors and clinical outcomes in adult kidney transplant recipients. Clinical Journal of the American Society of Nephrology 11(10):1845-55, 2016

Htay H, Cho Y, Pascoe EM, Darssan D, Hawley CM, Johnson DW on behalf of the balANZ Trial Investigators. Predictors of residual renal function decline in peritoneal dialysis patients: the balANZ trial. Peritoneal Dialysis International 37(3):283-9, 2017

Wing SN, Kelly J, Johnson DW, Campbell KL. Dietary patterns and clinical outcomes in chronic kidney disease: The CKD.QLD nutrition study. Journal of Renal Nutrition 27(3):175-82, 2017.

Irish AB, Viecelli AK, Hawley CM, Hooi LS, Pascoe EM, Paul-Brent PA, Badve SV, Mori TA, Cass A, Kerr PG, Voss D, Ong LM, Polkinghorne KR, for the Omega-3 Fatty Acids (Fish Oils) and Aspirin in Vascular Access Outcomes in Renal Disease (FAVOURED) Study Collaborative Group. The omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study – a randomized placebo-controlled trial. JAMA Internal Medicine 177(2):184-93, 2017.

Htay H, Johnson DW, Oei EL, Wu SY, Kong LP, Kwok CYH, Foo MWY, Cho JCJ. Comparison of topical chlorhexidine and mupirocin for the prevention of exit site infection in incident peritoneal dialysis patients. Peritoneal Dialysis International 37(3):266-72, 2017.

Saglimbene V, Palmer SC, Craig JC, Nicolucci A, Perkovic V, Tonelli M, Johnson DW, Lucisano G, Williams G, Valentini M, D’Alonzo D, Pellegrini F, Santoro A, Strippoli P, Triolo G, Salomone M, Maffei S, Ruospo M, Hegbrant J, Tognoni G, Strippoli GFM, for the CE-DOSE Study Investigators. Low versus high dose erythropoiesis-stimulating agents in hemodialysis patients with anemia: A randomized clinical trial. PLOS One. 12(3):e0172735, 2017.

Bello AK, A, Tonelli M, Okpechi IG, Feehally J, Harris DC, Jindal K, B, Rateb A, Osman MA, Qarn B, Saad S, Lunney M, Wiebe1 N, Ye F, Johnson DW. Assessment of global kidney health care status. JAMA 317(18):1864-1881, 2017.

Lee G, Krishnasamy R, Hawley CM, Johnson DW. The impact of Fibroblast Growth Factor-23 on the cardiovascular system in chronic kidney disease. Expert Review of Endocrinology & Metabolism 10(6):565-8, 2015.

Chan S, Au K, Francis RS, Mudge DW, Johnson DW, Pillans PI. Phosphate binders in patients with chronic kidney disease. Australian Prescriber 40(1):10-14, 2017.

Krishnasamy R, Hawley CM, Johnson DW. An update on bone imaging and markers in chronic kidney disease. Expert Review of Endocrinology & Metabolism 11(6):455-66, 2016.

Chan S, Oliver KA, Mallett AJ, Patel C, Francis RS, Johnson DW, Mudge DW, Isbel NM. Recurrent atypical haemolytic uraemic syndrome post kidney transplant due to a CD46 mutation in the setting of SMARCAL1-mediated inherited kidney disease. Nephrology 22 (Suppl 1):11-4, 2017.

Ludlow M, Mathew T, Usherwood T, Ramanathan S, Johnson DW, Fawcett K, Katz I. Australian general practitioners’ current practice for chronic kidney disease (CKD) detection and management. Australasian Medical Journal (In press; Acceptance date 9 June 2017).

Francis A, Johnson DW, Craig JC, Wong G. Moving on: transitioning young people with chronic kidney disease to adult care. Pediatric Nephrology (In press; Acceptance date 13 June 2017).

See EJ, Johnson DW, Hawley CM, Pascoe EM, Darssan D, Clayton PA, Borlace M, Badve SV, Sud K, Boudville N, Cho Y. Early peritonitis and its outcome in incident peritoneal dialysis patients. Pertioneal Dialysis International (In press; Acceptance date 12 June 2017).

Lo C, Toyama T, Hirakawa Y, Jun M, Cass A, Hawley C, Pilmore H, Badve SV, Perkovic V, Zoungas S, Wang Y, Lin J. Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease. Cochrane Database of Systematic Reviews 2015, Issue 8. Art. No.: CD011798. DOI: 10.1002/14651858.CD011798.

Lok CE, Rajan DK, Clement J, Kiaii M, Sidhu R, Thomson K, Buldo G, Dipchand C, Moist L, Sasal J on behalf of the NEAT Investigators. Endovascular proximal forearm arteriovenous fistula for hemodialysis acces: results of the prospective, multicenter novel endovascular access trial (NEAT). American Journal of Kidney Diseases 2017 Jun 9. pii: S0272-6386(17)30692-3. doi: 10.1053/j.ajkd.2017.03.026. [Epub ahead of print].

Gummer J, Trengove R, Pascoe EM, Badve SV, Cass A, Clarke P, McDonald SP, Morrish AT, Pedagogos E, Perkovic V, Reidlinger D, Scaria A, Walker R, Vergara LA, Carmel Hawley CM, Johnson DW, Olynk JK, Ferrari P on behalf of the HERO Study Collaborative Group. Association between Serum Hepcidin-25 and Primary Resistance to Erythropoiesis Stimulating Agents in Chronic Kidney Disease: A Secondary Analysis of the HERO Trial. Nephrology 22(7):548-54, 2017.

Ludlow M, Mathew T, Usherwood T, Ramanathan S, Fawcett K, Katz I, Johnson DW. Australian general practitioners’ current practice for chronic kidney disease (CKD) detection and management. Australasian Medical Journal (In press; Acceptance date 9 June 2017).

Lv J, Zhang H, Wong MG, Jardine MJ, Hladunewich M, Jha V, Monaghan H, Zhao M, Barbour S, Reich H, Cattran D, Glassock R, Levin A, Wheeler D, Woodward M, Billot L, Chan TM, Liu ZH, Johnson DW, Cass A, Feehally J, Floege J, Remuzzi G, Wu Y, Agarwal R, Wang HY, Perkovic V on behalf of the TESTING study group. Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy: the TESTING randomized clinical trial. JAMA (In press; Acceptance date 29 June 2017).

Jegatheesan D, Yang WL, Krishnasamy R, Hawley CM, Johnson DW. Cardiovascular disease in dialysis patients. In: Karkar A (ed), Dialysis, InTech, Rijeka, Croatia, 2017.

Ruospo M, Palmer SC Wong G, Craig JC, Petruzzi M, De Benedittis M, Ford P, Johnson DW, Tonelli M, Natale P, Saglimbene V, Pellegrini F, Celia E, Gelfman R, Leal MR, Torok M, Stroumza P, Bednarek-Skublewska A, Dulawa J, Frantzen L, Del Castillo D, Schon S, Bernat AG, Hegbrant J, Wollheim C, Gargano L, Bots CP, Strippoli, GFM on behalf of the ORALD Investigators. Periodontitis and early mortality among adults treated with hemodialysis: a multinational propensity-matched cohort study. BMC Nephrology 18:166, 2017.

Ng S, Johnson DW, Cho Y. Early onset peritoneal dialysis-related peritonitis. Journal of Clinical & Experimental Nephrology. 2(3):44, 2017.

Lo C, Toyama T, Wang Y, Lin J, Hirakawa Y, Jun M, Cass A, Hawley C, Pilmore H, Badve SV, Perkovic V, Zoungas S. Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease. Cochrane Database of Systematic Reviews 2015 , Issue 8 . Art. No.: CD011798. DOI: 10.1002/14651858.CD011798 .

Chan S, Cho Y, Koh YH, Boudville NC, Clayton PA, McDonald SP, Pascoe EM, Francis RS, Mudge DW, Borlace M, Badve SV, Sud K, Hawley CM, Johnson DW. Association of socio-economic position with technique failure and mortality in Australian non-indigenous peritoneal dialysis patients. Peritoneal Dialysis International 37(4):397-406, 2017.

See EJ, Cho Y, Hawley CM, Jaffrey LR, Johnson DW. Early and late patient outcomes in urgent start peritoneal dialysis. Peritoneal Dialysis International 37(4):414-9, 2017.

Htay H, Cho Y, Pascoe EM, Darssan D, Nadeau-Fredette AC, Hawley CM, Clayton PA, Borlace M, Badve SV, Sud K, Boudville N, McDonald SP, Johnson DW. Multi-center registry analysis of center characteristics associated with technique failure in incident peritoneal dialysis patients. Clinical Journal of the American Society of Nephrology 12(7):1090-9, 2017 (accompanied by editorial).

Lv J, Zhang H, Wong MG, Jardine MJ, Hladunewich M, Jha V, Monaghan H, Zhao M, Barbour S, Reich H, Cattran D, Glassock R, Levin A, Wheeler D, Woodward M, Billot L, Chan TM, Liu ZH, Johnson DW, Cass A, Feehally J, Floege J, Remuzzi G, Wu Y, Agarwal R, Wang HY, Perkovic V on behalf of the TESTING study group. Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy: the TESTING randomized clinical trial. JAMA 18(5):432-42, 2017.

Chan S, Au K, Francis RS, Mudge DW, Johnson DW, Pillans PI. Phosphate binders in patients with chronic kidney disease. Australian Prescriber 40:9-14, 2017.

Szeto CC, Johnson DW. Low GDP solution and glucose sparing strategies for peritoneal dialysis. Seminars in Nephrology 37(1):30-42, 2017.

Cho Y, Htay H, Johnson DW. Centre effects and peritoneal dialysis-related peritonitis. Nephrology Dialysis Transplantation 32(6):913-5, 2017.

Brown EA, Bargman J, van Biesen W, Chang MY, Finkelstein FO, Hurst H, Johnson DW, Kawanishi H, Lambie M, de Moraes TP, Morelle J, Woodrow G. Length of time on peritoneal dialysis and encapsulating peritoneal sclerosis: Position paper for ISPD – update 2017. Peritoneal Dialysis International 37(4):362-74, 2017.

Neuen BL, Chadban SJ, Demaio AR, Johnson DW, Perkovic V. Chronic kidney disease and the global NCDs agenda in 2017. BMJ Global Health 2:e000380, 2017.

Cho Y, Boudville N, Palmer SC, Chow JSF, Hawley CM, Jose MD, MacGinley R, Huang L, Moodie JA, Nguyen T, Robison L, Wong J, Johnson DW. Practice of peritoneal dialysis catheter flushing in Australia and New Zealand: a multi-centre cross-sectional survey. Peritoneal Dialysis International (In press; Acceptance date 14 August 2017).

Ellis RJ, Del Vecchio SJ, Ng KL, Dimeski G, Pascoe EM, Hawley CM, Johnson DW, Vesey DA, Coombes JS, Morais C, Francis RS, Wood ST, Gobe GC. Factors associated with acutely elevated serum creatinine following radical tumour nephrectomy: the CKD-TUNED study. Translational Andrology and Urology (In press; Acceptance date 21 August 2017).